로딩 중…
지수 로딩 중…
ArriVent BioPharma, Inc. Common Stock
AVBP· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$31.74+1.21%
2026-06-18
Price Chart
ArriVent BioPharma, Inc. Common Stock+27.52%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.48B |
| Revenue | $0.00 |
| Net Income | $-145M |
| Total Assets | $349M |
| Net Assets | $324M |
| Value | |
| P/B | 4.56x |
| FCF Yield | -9.10% |
| Profitability | |
| ROE | -44.83% |
| ROA | -41.58% |
| Financial Health | |
| Debt Ratio | 7.81% |
| Total Debt | $419000.00 |
| FCF | $-134M |
| Cash | $62M |
| Current Ratio | 13.95x |
| Performance | |
| 1Y Return | 27.52% |
| 1M Return | 21.38% |
| From 52W High | -5.59% |
| 1Y MDD | -33.32% |
| Trading | |
| Volume | 591,030 shares |
| Trading Value | $19M |
| Per Share | |
| EPS | $-4.32 |
| BPS | $7.99 |